A U.S. District Court jury has concluded that a wound therapy product sold by Smith & Nephew plc infringes two patents owned by Wake Forest University Health Sciences, which are exclusively licensed to Kinetic Concepts Inc. (KCI).

KCI will be seeking an injunction in the United States District Court in post-trial proceedings to prevent further infringement by Smith & Nephew of its V.A.C. technology, according to the San Antonio, Texas-based company.

“The outcome of this trial exemplifies the protections provided to innovators like Wake Forest and KCI under the U.S. patent system,” said Catherine Burzik, KCI’s president and CEO.

KCI manufactures medical devices for the wound care, tissue regeneration and therapeutic support system markets. Smith & Nephew, which manufactures devices for the orthopedics, wound management and endoscopy markets, is headquartered in London, England.

Smith & Nephew was not immediately available for comment.